Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Monday, September 28, 2026

Back to today

From X

@KEDM_COM 2 clicks

KEDM.com on X

Right Tail @JeremyKokemor bought $HCA at about 12x earnings on a local-density argument: hospitals compete neighborhood by neighborhood, and HCA holds #1 or #2 share — averaging 25-30% of each market in about 80% of its markets, primarily in Sunbelt states. Outpatient access points — 14 per hospital, heading toward 20 — feed the hospitals, and about 75% of admissions arrive through the ER. Margins held in the high teens through 2009, and half the shares have been retired since the 2011 re-IPO. Historically, HCA has compounded revenue at roughly 7% annually and EPS closer to 17%; Right Tail models mid-single-digit revenue growth and 10-15% EPS growth.
@Fierce__beast 1 click

Fierce_beast on X

Here's the J-curve stock shape -- many examples of software stocks and high growth stocks, sometimes even large mature companies that release a new product. $MPWR was shaping up for this in November 2024 (I wrote about this and went long) when it dropped a lot after they "lost $NVDA" marketshare, but of course their custom AI accelerator business was growing something like 100% a year, and it was only a matter of time before it showed up in the earnings. It subsequently re-rated after troughing at 35x and had significant earnings growth. Today it goes for 35x again. Will there be another big bump in a few years, maybe robotics?
@Fierce__beast 1 click

Fierce_beast on X

This is the shape of many AI related beneficiaries that I think is the most likely path, a few bumps along the way of course, but more or less the path: $AVGO is an interesting example it has expected EPS growth that looks almost exactly like this, but it doesn't trade for 67.5x, it trades for 20x, which seems to imply that earnings growth rate expectations will pretty dramatically slow down within the next 12-24 months. This doesn't seem likely to me. Of course when I say expected EPS these views are extrapolations of near-term trends and discussions about long-term demand, but all i am making a point about is that if $AVGO's estimates actually materialize roughly like the consensus estimates think, the stock should probably be at least 100% higher.

Investor Letters

All letters

Hindsight Capital

Hindsight Capital tests crisis-era investment decisions using anonymized company financials, including TransDigm, Halma and Texas Pacific…

TDG $60BTPL $23B
Rebound Capital 6 clicks

The Brookfield Moat Masterclass

Brookfield’s BN, BAM, BIP, BEP and BBUC span asset management, infrastructure, renewables and private equity, with BN valued at a 15–20%…

BN $82B
Brad Thomas
CBOE · long

Cboe Global Markets INC

Cboe Global Markets trades near $232, with a roughly $24.3 billion market cap, net cash and a 16-17x forward P/E.

CBOE $29B
Value Investors Club 3 clicks

Reddit: DCF Valuation

Reddit’s DCF values shares at $225, driven by international ARPU expansion from $2.2 to $8.3 by 2035 and 38% operating margins.

RDDT $28B
Hated Moats 7 clicks

The Agents Revolt

Meta’s Muse reached 2.8 million downloads in two weeks, using AI agents to automate insurance shopping and erode customer inertia that…

META $1.8T
Net Interest 6 clicks

Publications we follow

Every publication on this site, hand-picked.

110 publications

Newsletters 93

YouTube 4

Blogs 12

Seeking Alpha 42 of 199

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

72 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.